MERGERS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Good news for any of you who slept through December 2017: You didn't miss much—at least as far as blockbuster strategic deals in the clinical laboratory space are concerned. M&AIn contrast to … [Read more...]

DISTRIBUTION AGREEMENTS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

The pattern of high volume and relatively low impact continued with strategic alliances outnumbering acquisitions at rate of roughly 3:1. M&A Following the trio of mega-deal closings, … [Read more...]

MARKETING

Report: Outreach Labs Remain Profitable Despite Antiquated Systems & Lack of Exec Respect

Hidden within the basement of your average hospital is a $24 million business, one that provides a top quality, must-have service and operates at a margin of around 25% to 30%. That business is the … [Read more...]

GREAT TRANSITION UNDERWAY

Laboratories Increasing Customer-Focus

Laboratories have always had a strong service component—both for their referring physicians and the patient. However, laboratories are now in the midst of a great transition, where a concerted … [Read more...]

AGREEMENTS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Deal volume was high during the month. But most of the deals were small and research-based. M&A It took over 18 months but the Abbott-Alere merger finally closed on Oct. 3. Alere got quite the … [Read more...]

MARKETING

Market Trends: Celebrity Power to Drive Testing Goes Beyond the ‘Angelina Jolie Effect’

The rates of genetic testing among women supposedly soared after Angelina Jolie revealed that she had undergone a double mastectomy to reduce her chances of developing breast cancer after learning … [Read more...]

COMPLIANCE

You Make the Call: Is Replacing Spoiled Products for Free an Anti-Kickback Violation?

The following scenario comes right out of an August 25, 2017 OIG Advisory Opinion. See if you can guess how the OIG ruled. SITUATION A pharmaceutical company manufactures biologics prone to spoilage … [Read more...]

ACQUISITIONS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Strategic alliance rather than M&A remains the preferred form of strategic interaction in the lab industry. M&A The preference of diagnostic companies to work with rather than digest each … [Read more...]

MARKETING

Inside the Lab Industry: The Surge of Do-It-Yourself Test Kits

Consumerism, patient empowerment and affordability are key drivers in the modern medical industry. One of the key manifestations of this within the clinical laboratories sector is the rapid growth of … [Read more...]

NEWS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

It's been a relatively quiet month on the diagnostic front in terms of both deal volume and impact. Here's a rundown of the deals that did come down. M&A CRO acquisitions were the M&A … [Read more...]


(-0000g2)